Related Experiment Video
Updated: Apr 16, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome
Hector L Franco1, Anusha Nagari1, W Lee Kraus1
1Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences and Division of Basic Reproductive Biology Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
The interplay between mitogenic and proinflammatory signaling pathways plays key roles in determining the phenotypes and clinical outcomes of breast cancers. Using GRO-seq in MCF-7 cells, we defined the immediate transcriptional effects of crosstalk between estradiol (E2) and TNFα, identifying a large set of target genes whose expression is rapidly altered with combined E2 + TNFα treatment, but not with either agent alone. The pleiotropic effects on gene transcription in response to E2 + TNFα are orchestrated by extensive remodeling of the ERα enhancer landscape in an NF-κB- and FoxA1-dependent manner. In addition, expression of the de novo and synergistically regulated genes is strongly associated with clinical outcomes in breast cancers. Together, our genomic and molecular analyses indicate that TNFα signaling, acting in pathways culminating in the redistribution of NF-κB and FoxA1 binding sites across the genome, creates latent ERα binding sites that underlie altered patterns of gene expression and clinically relevant cellular responses.
Insights
Combined estradiol (E2) and tumor necrosis factor alpha (TNFα) signaling rapidly alters gene expression in breast cancer cells. This crosstalk creates new estrogen receptor alpha (ERα) binding sites, influencing cancer phenotypes and clinical outcomes.
Area of Science:
- Molecular biology
- Cancer research
- Genomics
Background:
- Mitogenic and proinflammatory pathways significantly impact breast cancer phenotypes and outcomes.
- Understanding the crosstalk between estradiol (E2) and tumor necrosis factor alpha (TNFα) signaling is crucial for breast cancer research.
Purpose of the Study:
- To define the immediate transcriptional effects of E2 and TNFα crosstalk in breast cancer cells.
- To investigate the genomic mechanisms underlying gene expression changes induced by combined E2 + TNFα treatment.
Main Methods:
- Utilized GRO-seq (Global Run-On sequencing) in MCF-7 breast cancer cells.
- Analyzed transcriptional responses to individual and combined E2 and TNFα treatments.
- Investigated enhancer remodeling and transcription factor binding site redistribution (NF-κB, FoxA1).
Main Results:
- Identified a large set of target genes rapidly altered by combined E2 + TNFα, but not by either agent alone.
- Demonstrated extensive remodeling of the estrogen receptor alpha (ERα) enhancer landscape dependent on NF-κB and FoxA1.
- Found that expression of synergistically regulated genes is strongly associated with breast cancer clinical outcomes.
Conclusions:
- TNFα signaling, through NF-κB and FoxA1, creates latent ERα binding sites, altering gene expression patterns.
- This crosstalk influences clinically relevant cellular responses in breast cancer.
- Genomic and molecular analyses reveal a novel mechanism of gene regulation in breast cancer.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Signal Transduction: Overview
Typically, signal transduction involves three...
Internal Receptors
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

